RxNorm September 2024 Monthly Release

RxNorm September 2024 Monthly Release. NLM Tech Bull. 2024 Sep-Oct;(460):b3.

The RxNorm September 2024 monthly release became available on Tuesday, September 3, 2024. This release includes updated COVID-19 vaccines.

The U.S. Food and Drug Administration (FDA) approved and authorized for emergency use updated COVID-19 vaccines formulated to better protect against currently circulating variants (FDA news release).

Here are the new RxNorm COVID-19-related concepts:

Moderna EUA

• RXCUI 2691172: 0.25 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe

Pfizer-BioNTech EUA

• RXCUI 2691196: SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML Injectable Suspension
• RXCUI 2691200: 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.0333 MG/ML Injection

Comirnaty

• RXCUI 2691212: 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe [Comirnaty 2024-2025]
• RXCUI 2691219: 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.1 MG/ML Injection [Comirnaty 2024-2025] 

Spikevax

• RXCUI 2691189: 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Injection [Spikevax 2024-2025]
• RXCUI 2691181: 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe [Spikevax 2024-2025]

Get more information about Emergency Use Authorization (EUA) from the FDA.

Get more information about RxNorm’s policy change on investigational drugs from the National Library of Medicine.